EDGAR·FLOW

Aptevo Therapeutics Inc. — Form S-1

Filed November 20, 2026 · analyzed by the Registration Agent
S-1 ▼ Likely negative significance 72/100
What the filing says
Aptevo issued 13,888,890 Inducement Warrants on November 11, 2026 to three warrant holders (Armistice Capital, Hudson Bay, Sabby Volatility) at $1.08/share exercise price in exchange for immediate cash exercise of 2,777,778 existing warrants at reduced $1.08 price. The company received ~$3.0M gross proceeds from warrant exercise; if Inducement Warrants are exercised in full, company would receive ~$15.0M additional. Resale shares represent 79% of post-offering outstanding shares (13.9M of 17.5M total). Stock price on November 19, 2026: $0.41/share. This is a shelf registration for resale of warrant-exercise shares.
Why this rating

Massive dilution (79% share increase post-offering) relative to tiny $9.8M market cap; warrant exercise terms highly unfavorable to shareholders. Material capital raise offsets some concern.

Extracted items
Price action (we called it negative)
before filing · preread
$0.40
at our read
pending
+10 min
pending
+30 min
pending
+1 hr
pending
+4 hrs
pending

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ APVO · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.